Low-density lipoprotein cholesterol was inversely associated with 3-year all-cause mortality among Chinese oldest old: data from the Chinese Longitudinal Healthy Longevity Survey.

[1]  S. Akifusa,et al.  Serum total cholesterol concentration and 10-year mortality in an 85-year-old population , 2014, Clinical interventions in aging.

[2]  D. Sheps,et al.  Low Levels of Low-Density Lipoprotein Cholesterol: A Negative Predictor of Survival in Elderly Patients with Advanced Heart Failure , 2013, Cardiology.

[3]  J. Blacher,et al.  Prognosis in the hospitalized very elderly: the PROTEGER study. , 2013, International journal of cardiology.

[4]  S. Fu,et al.  Prevalence, clinical predictors, and prognostic impact of chronic renal insufficiency in very old Chinese patients with coronary artery disease , 2013, Aging Clinical and Experimental Research.

[5]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[6]  S. M. de Andrade,et al.  Lipids and All-Cause Mortality among Older Adults: A 12-Year Follow-Up Study , 2012, TheScientificWorldJournal.

[7]  Yi Zeng,et al.  [Main dimensions of health status among the Chinese elderly]. , 2010, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[8]  F. Irie,et al.  Low-Density Lipoprotein Cholesterol Concentrations and Death Due to Intraparenchymal Hemorrhage: The Ibaraki Prefectural Health Study , 2009, Circulation.

[9]  Jersey Liang,et al.  Health among the oldest-old in China: which living arrangements make a difference? , 2009, Social science & medicine.

[10]  S. Feasson,et al.  MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals : a randomised placebo-controlled trial. , 2008 .

[11]  Danan Gu,et al.  General Data Quality Assessment of the CLHLS , 2008 .

[12]  D. Gu,et al.  Healthy Longevity in China , 2008 .

[13]  M. Woodward,et al.  Associations Between Serum Lipids and Causes of Mortality in a Cohort of 3499 Urban Thais: The Electricity Generating Authority of Thailand (EGAT) Study , 2007, Angiology.

[14]  M. Boaz,et al.  Low serum LDL cholesterol levels and the risk of fever, sepsis, and malignancy. , 2007, Annals of clinical and laboratory science.

[15]  S. Iliceto,et al.  Non-Cardiovascular Mortality, Low-Density Lipoprotein Cholesterol and Statins: A Meta-Regression Analysis , 2007, Cardiology.

[16]  [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. , 2007, Zhonghua xin xue guan bing za zhi.

[17]  Gfr Investigation.  Modification and evaluation of MDRD estimating equation for Chinese patients with chronic kidney disease , 2006 .

[18]  J. Staessen,et al.  Low‐Density Lipoprotein Cholesterol and Mortality in Older People , 2005, Journal of the American Geriatrics Society.

[19]  R. Mayeux,et al.  Relationship Between Plasma Lipids and All‐Cause Mortality in Nondemented Elderly , 2005, Journal of the American Geriatrics Society.

[20]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[21]  B. Hedblad,et al.  Fatality of Future Coronary Events Is Related to Inflammation-Sensitive Plasma Proteins: A Population-Based Prospective Cohort Study , 2004, Circulation.

[22]  G. Mancia,et al.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force Of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). , 2004, Archives des maladies du coeur et des vaisseaux.

[23]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[24]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2004, European heart journal.

[25]  D. Inzitari,et al.  Low Total Cholesterol and Increased Risk of Dying: Are Low Levels Clinical Warning Signs in the Elderly? Results from the Italian Longitudinal Study on Aging , 2003, Journal of the American Geriatrics Society.

[26]  P. Macfarlane,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.

[27]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[28]  J. Tuomilehto,et al.  Serum cholesterol and depressive symptoms in elderly Finnish men , 2002, International journal of geriatric psychiatry.

[29]  M. Delgado-Rodríguez,et al.  Cholesterol and serum albumin levels as predictors of cross infection, death, and length of hospital stay. , 2002, Archives of surgery.

[30]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .

[32]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  K. Yano,et al.  Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study , 2001, The Lancet.

[34]  A. Weverling-Rijnsburger,et al.  Total cholesterol and risk of mortality in the oldest old , 1997, The Lancet.

[35]  M. Netea,et al.  Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. , 1996, The Journal of clinical investigation.

[36]  Scandinavian Simvastatin Survival Study Group.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[37]  B. Psaty,et al.  The Association between Cholesterol and Death from Injury , 1994, Annals of Internal Medicine.

[38]  W. Aronow,et al.  Correlation of serum lipids with the presence or absence of coronary artery disease in 1,793 men and women aged > or = 62 years. , 1994, The American journal of cardiology.

[39]  M. Marmot,et al.  Plasma cholesterol concentration and mortality. The Whitehall Study. , 1992, JAMA.